Why Tandem Diabetes Care Stock Took It on the Chin Tuesday

Flat revenue growth might be in store for the company in a very crucial market. An analyst issued the equivalent of a warning on Tandem Diabetes Care (TNDM -3.16%) stock on the second trading day of the week and, absent any other news for the company, some investors traded out of it. This left Tandem's shares with a more than 3% loss in price on the day, which compared unfavorably to the sub-1% decline of the bellwether S&P 500 index. Citi advises keeping watch on the stock The prognosticator behind that pi ...